Evolving patterns and clinical outcome of genetic studies performed at diagnosis in acute myeloid leukemia patients: Real life data from the PETHEMA Registry.

Autor: Labrador J; Hospital Universitario de Burgos, Burgos, Spain., Martínez-Cuadrón D; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Boluda B; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Serrano J; Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain., Gil C; Hospital General Universitario de Alicante, Alicante, Spain., Pérez-Simón JA; Hospital Universitario Virgen del Rocío, Instituto de Biomedicina de Sevilla (IBIS/CSIC), Sevilla, Spain., Bernal T; Hospital Universitario Central Asturias, ISPA, IUOPA, Oviedo, Spain., Bergua JM; Hospital San Pedro de Alcántara, Cáceres, Spain., Martínez-López J; Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid, Spain., Rodríguez-Medina C; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Vidriales MB; Hospital Universitario de Salamanca, Salamanca, Spain., García-Boyero R; Hospital General Universitario de Castellón, Castellón de la Plana, Spain., Algarra L; Hospital General Universitario de Albacete, Albacete, Spain., Polo M; Hospital Clínico San Carlos, Madrid, Spain., Sayas MJ; Hospital Universitario Doctor Peset, Valencia, Spain., Tormo M; Hospital Clínico Universitario de Valencia, Valencia, Spain., Alonso-Domínguez JM; Hospital Universitario Fundación Jiménez Díaz, Madrid, Spain., Herrera P; Hospital Universitario Ramón y Cajal, Madrid, Spain., Lavilla E; Hospital Universitario Lucus Augusti, Lugo, Spain., Ramos F; Hospital Universitario de León, León, Spain., Amigo ML; Hospital General Universitario Morales Meseguer, Murcia, Spain., Vives-Polo S; Hospital Germans Trias i Pujol-ICO, Badalona, Spain., Rodríguez-Macías G; Hospital General Universitario Gregorio Marañón, Madrid, Spain., Mena-Durán A; Hospital General de Valencia, Valencia, Spain., Pérez-Encinas MM; Hospital Clínico Universitario de Santiago, Santiago de Compostela, Spain., Arce-Fernández O; Hospital de Basurto, Bilbao, Spain., Cuello R; Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Sánchez-García J; Hospital Universitario Reina Sofía, IMIBIC, Córdoba, Spain., Gómez-Casares MT; Hospital Universitario de Gran Canaria Doctor Negrín, Las Palmas de Gran Canaria, Spain., Chillón MC; Hospital Universitario de Salamanca, Salamanca, Spain., Calasanz MJ; CIMA Lab Diagnostics. Universidad de Navarra, Pamplona, Spain., Ayala R; Hospital Universitario 12 de Octubre, Complutense University, i+12, CNIO, Madrid, Spain., Rodriguez-Veiga R; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Barragán E; Hospital Universitari I Politécnic La Fe, Valencia, Spain., Montesinos P; Hospital Universitari I Politécnic La Fe, Valencia, Spain.

Publikováno v: Cancer [Cancer] 2024 Oct 15; Vol. 130 (20), pp. 3436-3451. Date of Electronic Publication: 2024 Jun 19.

Unraveling druggable cancer-driving proteins and targeted drugs using artificial intelligence and multi-omics analyses.

Autor: López-Cortés, Andrés¹ aalc84@gmail.com, Cabrera-Andrade, Alejandro^2,3, Echeverría-Garcés, Gabriela^4,5, Echeverría-Espinoza, Paulina¹, Pineda-Albán, Micaela¹, Elsitdie, Nicole¹, Bueno-Miño, José¹, Cruz-Segundo, Carlos M.^6,7, Dorado, Julian^6,8, Pazos, Alejandro^6,8,9, Gonzáles-Díaz, Humberto^10,11, Pérez-Castillo, Yunierkis², Tejera, Eduardo², Munteanu, Cristian R.^6,8,9

Publikováno v: Scientific Reports. 8/21/2024, Vol. 14 Issue 1, p1-22. 22p.

Diversifying the anthracycline class of anti-cancer drugs identifies aclarubicin for superior survival of acute myeloid leukemia patients.

Autor: Qiao, Xiaohang^1,2 (AUTHOR) x.qiao@nki.nl, van der Zanden, Sabina Y.³ (AUTHOR), Li, Xiaoyang⁴ (AUTHOR), Tan, Minkang³ (AUTHOR), Zhang, Yunxiang⁴ (AUTHOR), Song, Ji-Ying⁵ (AUTHOR), van Gelder, Merle A.³ (AUTHOR), Hamoen, Feija L.³ (AUTHOR), Janssen, Lennert³ (AUTHOR), Zuur, Charlotte L.^1,2 (AUTHOR), Pang, Baoxu³ (AUTHOR), van Tellingen, Olaf⁶ (AUTHOR), Li, Junmin^4,7 (AUTHOR) drlijunmin@126.com, Neefjes, Jacques³ (AUTHOR) j.j.c.neefjes@lumc.nl

Publikováno v: Molecular Cancer. 6/4/2024, Vol. 23 Issue 1, p1-16. 16p.

Comparison of allo-SCT, auto-SCT and chemotherapy for the treatment of patients with low- or intermediate-risk acute myeloid leukemia: a network meta-analysis.

Autor: Ye, Wu¹ (AUTHOR), Wu, Xia¹ (AUTHOR), Zhao, Ruying² (AUTHOR), Jin, Xuelian¹ (AUTHOR), Li, Hui² (AUTHOR), Qu, Ying¹ (AUTHOR), Ji, Jie¹ (AUTHOR) jieji@scu.edu.cn, Liu, Zhigang¹ (AUTHOR) hxdoctorliu@126.com

Publikováno v: Stem Cell Research & Therapy. 5/31/2024, Vol. 15 Issue 1, p1-14. 14p.

Pursuing dynamics of minimal residual leukemic subclones in relapsed and refractory acute myeloid leukemia during conventional therapy.

Autor: Kim, Dongchan^1,2 (AUTHOR), Kim, Sheehyun^2,3 (AUTHOR), Song, Hyojin^2,3 (AUTHOR), Gwak, Daehyeon^1,2 (AUTHOR), Min, Suji^1,2 (AUTHOR), Byun, Ja Min^1,2,4 (AUTHOR), Koh, Youngil^1,2,4 (AUTHOR), Hong, Junshik^1,2,4 (AUTHOR), Yoon, Sung‐Soo^1,2,4 (AUTHOR), Yun, Hongseok^2,3 (AUTHOR) entropy.yun@gmail.com, Shin, Dong‐Yeop^1,2,4 (AUTHOR) shindongyeop@snu.ac.kr

Publikováno v: Cancer Medicine. Apr2024, Vol. 13 Issue 7, p1-9. 9p.